SCHEMBL17279043

SCHEMBL17279043

C=CC(=O)OCCCCCCCCCCCOc1ccc(COc2ccc(OC(=O)c3ccc(OCCCCCCCCCCCOC(=O)C=C)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.47
▸ THRB P10828 2/20 0.47
▸ CYP3A4 P08684 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NPC1 O15118 5/20 0.46
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ PTPRC P08575 1/20 0.43
▸ PTPN2 P17706 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12963215 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL19497707 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL12963211 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL18806599 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL12963210 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL12963216 1.00 HTT (0.47) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL12604141 0.99 HTT (0.46) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL16996738 0.96 HTT (0.44) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL16996731 0.96 HTT (0.44) HTTTHRBCYP3A4ALDH1A1TSHR
SCHEMBL19224204 0.95 HTT (0.44) HTTTHRBCYP3A4ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240069264-A1 LAMINATE, REFLECTION PREVENTION SYSTEM, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2024-02-29 — — US disclosed
US-20230314854-A1 LIGHT ABSORPTION ANISOTROPIC FILM, VIEWING ANGLE CONTROL SYSTEM, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-10-05 — — US disclosed
US-20230265346-A1 LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-08-24 — — US disclosed
US-20230159827-A1 LIQUID CRYSTAL COMPOSITION, FLUORINE-CONTAINING POLYMER, OPTICALLY ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-05-25 — — US disclosed
US-10023743-B2 Dichroic pigment compounds and compositions containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-07-17 — — US disclosed
US-10005960-B2 Composition and polarizing film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-06-26 — — US disclosed
US-20180072890-A1 COMPOUND AND COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-15 — — US disclosed
US-20180030354-A1 COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-01 — — US disclosed
US-20170242169-A1 DICHROIC DYE COMPOUND, POLARIZING FILM, AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-24 — — US disclosed
US-20170240810-A1 DICHROIC DYE COMPOUND, POLARIZING FILM, AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-24 — — US disclosed
US-9644148-B2 Liquid Crystal composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-09 — — US disclosed
US-20170121605-A1 COMPOSITION AND POLARIZING FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-04 — — US disclosed
US-20150337203-A1 COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150337203-A1 COMPOSITION CRY1, CRY2, C5 HTT 1794/4885THRB 4043/4885CYP3A4 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback